2nd Annual Precision Liver Symposium

The Second Annual Thursday Liver Symposium: Dawn of a New Era in Precision Medicine: Genetics and Biomarkers in Liver Disease and Cirrhosis

[2nd Annual Precision Liver Symposium @precisionliver]

Faculty at the #Precisionmedicinesympo 🩺!

[2nd Annual Precision Liver Symposium @precisionliver]

Happening Now! 🎤 The Precision Medicine Liver Symposium is in full swing packed with dynamic discussions, new data, and expert perspectives driving progress in liver disease management.

[2nd Annual Precision Liver Symposium @precisionliver]

Welcome to the #Precisionmedicinesympo ⭐

[2nd Annual Precision Liver Symposium @precisionliver]

There’s still time to register for the Thursday Liver Symposium!

Hear from Dr. Naga Chalasani as he dives into cutting-edge topics including PNPLA3, Resmetirom, FGF-21, and GLP-1 analogues—and what they mean for liver disease management.

👉 Register: https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Join us at the Thursday Liver Symposium for an expert session with Dr. Naim Alkhouri, MD, FAASLD, DABOM — “Event Rate in MASH Cirrhosis Trials by VCTE: Assessment of the Phase 3 Trial Landscape.”

Register: https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Dr. Rohit Loomba leads Second Annual Thursday Liver Symposium on November 6th - Register Now!: https://t.co/g8ORkSWwLP @DrLoomba

[2nd Annual Precision Liver Symposium @precisionliver]

🔥 Debate Spotlight : Should patients with burnt-out NASH be included in cirrhosis trials?

Don’t miss this thought-provoking session as two leading experts go head-to-head on one of the most important questions in liver research.

👉 Register now: https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Register now for the Second Annual Thursday Liver Symposium on Thursday, November 6th!

Don’t miss Dr. Rohit Loomba as he presents new data on cT1, MRE, and MRI-PDFF in treatment response. @DrLoomba

👉 Secure your spot now!: https://t.co/NajgvUc2Rs

[2nd Annual Precision Liver Symposium @precisionliver]

Don’t miss this session at the Thursday Liver Sympo! 📢

Guadalupe Garcia-Tsao, MD, FRCP will break down the key NEJM papers on SLD and cirrhosis, highlighting the latest evidence and what it means for patient care.

👉 Seats are limited—register now at https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Learn from the experts at the Second Annual Thursday Liver Symposium!
Cutting-edge updates, practical strategies, and leading voices in liver care—all in one event.

Register now: https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Join us in Washington, DC!
The Second Annual Thursday Liver Symposium takes place November 6th. Don’t miss this opportunity to connect, learn, and advance care in liver disease.

👉 https://t.co/g8ORkSWwLP

[2nd Annual Precision Liver Symposium @precisionliver]

Dr. Rohit Loomba leads the Second Annual Thursday Liver Symposium on November 6th - Register Now!: https://t.co/g8ORkSWwLP

[Rohit Loomba @DrLoomba]

Kick starting ⁦@MetALDconf⁩ in San Diego how to diagnose metALD in clinic ? ⁦@AjmeraVeeral⁩ ⁦@AASLDtweets⁩ ⁦@AmerGastroAssn⁩ ⁦@QAnstee⁩ ⁦@AleksanderKrag⁩

[Luis Antonio Díaz, MD @LuisAntonioDiaz]

Great talk @juanpabloarab on the impact of alcohol use in the natural history of SLD at the @MetALDconf . Assessment of alcohol intake over time should be standardized in clinical practice. @VCU @VCU_Liver @DrLoomba @MarcoArreseMD @rabataller @ArunJSanyalVCU

[Luis Antonio Díaz, MD @LuisAntonioDiaz]

Pros and cons of current NITs in MetALD. Inflammation, excess weight, alcohol use and low specificity are the main caveats of NITs. Fantastic talk from @MajaThiele at the @MetALDconf ! #LiverTwitter @DrLoomba @AleksanderKrag @EASLedu @EASLnews @MASLDResearch

[Luis Antonio Díaz, MD @LuisAntonioDiaz]

How to innovate in MetALD clinical trials? @DrLoomba provided relevant considerations for security and endpoints. NITs biomarkers may play a role in early phase studies! @MASLDResearch @f_tavaglione @DrMaralMD @AjmeraVeeral @MonicaTincopa @UCSD_GI #LiverTwitter @MetALDconf

[2nd Annual Precision Liver Symposium @precisionliver]

Ending the day with the Emerging Biomarkers and Endpoints panel discussion!

[2nd Annual Precision Liver Symposium @precisionliver]

Excessive Alcohol Use and Alcohol Use Disorder in MetALD Trials session discussion with our esteemed panelists!

[2nd Annual Precision Liver Symposium @precisionliver]

Thank you to the MetALD Conference faculty for an excellent day of lectures and insightful learning!

[2nd Annual Precision Liver Symposium @precisionliver]

Natural History and Biomarkers of Liver Injury and Alcohol Use in MetALD Panel Discussion live at the MetALD Conference!